Global Hyper Immune Globulin Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
LPI (LP Information)' newest research report, the “Hyper Immune Globulin Industry Forecast” looks at past sales and reviews total world Hyper Immune Globulin sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyper Immune Globulin sales for 2023 through 2029. With Hyper Immune Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyper Immune Globulin industry.
This Insight Report provides a comprehensive analysis of the global Hyper Immune Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyper Immune Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hyper Immune Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyper Immune Globulin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyper Immune Globulin.
The global Hyper Immune Globulin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hyper Immune Globulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hyper Immune Globulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hyper Immune Globulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hyper Immune Globulin players cover CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyper Immune Globulin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Hyper Immune Globulin market?
What factors are driving Hyper Immune Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyper Immune Globulin market opportunities vary by end market size?
How does Hyper Immune Globulin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
LPI (LP Information)' newest research report, the “Hyper Immune Globulin Industry Forecast” looks at past sales and reviews total world Hyper Immune Globulin sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyper Immune Globulin sales for 2023 through 2029. With Hyper Immune Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyper Immune Globulin industry.
This Insight Report provides a comprehensive analysis of the global Hyper Immune Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyper Immune Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hyper Immune Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyper Immune Globulin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyper Immune Globulin.
The global Hyper Immune Globulin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hyper Immune Globulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hyper Immune Globulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hyper Immune Globulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hyper Immune Globulin players cover CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyper Immune Globulin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Hepatitis B Immunoglobulins
- Rabies Immunoglobulins
- Tetanus Immunoglobulins
- Rho(D) Immunoglobulins
- Others
- Government Institutions
- Private Sector
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Grifols
- Biotest
- Kedrion
- CBPO
- Emergent (Cangene)
- Kamada
- CNBG
- Hualan Bio
- Shanghai RAAS
- Sichuan Yuanda Shuyang
- ADMA Biologics
What is the 10-year outlook for the global Hyper Immune Globulin market?
What factors are driving Hyper Immune Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyper Immune Globulin market opportunities vary by end market size?
How does Hyper Immune Globulin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hyper Immune Globulin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hyper Immune Globulin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hyper Immune Globulin by Country/Region, 2018, 2022 & 2029
2.2 Hyper Immune Globulin Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Others
2.3 Hyper Immune Globulin Sales by Type
2.3.1 Global Hyper Immune Globulin Sales Market Share by Type (2018-2023)
2.3.2 Global Hyper Immune Globulin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hyper Immune Globulin Sale Price by Type (2018-2023)
2.4 Hyper Immune Globulin Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Others
2.5 Hyper Immune Globulin Sales by Application
2.5.1 Global Hyper Immune Globulin Sale Market Share by Application (2018-2023)
2.5.2 Global Hyper Immune Globulin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hyper Immune Globulin Sale Price by Application (2018-2023)
3 GLOBAL HYPER IMMUNE GLOBULIN BY COMPANY
3.1 Global Hyper Immune Globulin Breakdown Data by Company
3.1.1 Global Hyper Immune Globulin Annual Sales by Company (2018-2023)
3.1.2 Global Hyper Immune Globulin Sales Market Share by Company (2018-2023)
3.2 Global Hyper Immune Globulin Annual Revenue by Company (2018-2023)
3.2.1 Global Hyper Immune Globulin Revenue by Company (2018-2023)
3.2.2 Global Hyper Immune Globulin Revenue Market Share by Company (2018-2023)
3.3 Global Hyper Immune Globulin Sale Price by Company
3.4 Key Manufacturers Hyper Immune Globulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyper Immune Globulin Product Location Distribution
3.4.2 Players Hyper Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HYPER IMMUNE GLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Hyper Immune Globulin Market Size by Geographic Region (2018-2023)
4.1.1 Global Hyper Immune Globulin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hyper Immune Globulin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyper Immune Globulin Market Size by Country/Region (2018-2023)
4.2.1 Global Hyper Immune Globulin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hyper Immune Globulin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyper Immune Globulin Sales Growth
4.4 APAC Hyper Immune Globulin Sales Growth
4.5 Europe Hyper Immune Globulin Sales Growth
4.6 Middle East & Africa Hyper Immune Globulin Sales Growth
5 AMERICAS
5.1 Americas Hyper Immune Globulin Sales by Country
5.1.1 Americas Hyper Immune Globulin Sales by Country (2018-2023)
5.1.2 Americas Hyper Immune Globulin Revenue by Country (2018-2023)
5.2 Americas Hyper Immune Globulin Sales by Type
5.3 Americas Hyper Immune Globulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyper Immune Globulin Sales by Region
6.1.1 APAC Hyper Immune Globulin Sales by Region (2018-2023)
6.1.2 APAC Hyper Immune Globulin Revenue by Region (2018-2023)
6.2 APAC Hyper Immune Globulin Sales by Type
6.3 APAC Hyper Immune Globulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hyper Immune Globulin by Country
7.1.1 Europe Hyper Immune Globulin Sales by Country (2018-2023)
7.1.2 Europe Hyper Immune Globulin Revenue by Country (2018-2023)
7.2 Europe Hyper Immune Globulin Sales by Type
7.3 Europe Hyper Immune Globulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hyper Immune Globulin by Country
8.1.1 Middle East & Africa Hyper Immune Globulin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hyper Immune Globulin Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyper Immune Globulin Sales by Type
8.3 Middle East & Africa Hyper Immune Globulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyper Immune Globulin
10.3 Manufacturing Process Analysis of Hyper Immune Globulin
10.4 Industry Chain Structure of Hyper Immune Globulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyper Immune Globulin Distributors
11.3 Hyper Immune Globulin Customer
12 WORLD FORECAST REVIEW FOR HYPER IMMUNE GLOBULIN BY GEOGRAPHIC REGION
12.1 Global Hyper Immune Globulin Market Size Forecast by Region
12.1.1 Global Hyper Immune Globulin Forecast by Region (2024-2029)
12.1.2 Global Hyper Immune Globulin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyper Immune Globulin Forecast by Type
12.7 Global Hyper Immune Globulin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyper Immune Globulin Product Portfolios and Specifications
13.1.3 CSL Behring Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyper Immune Globulin Product Portfolios and Specifications
13.2.3 Grifols Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyper Immune Globulin Product Portfolios and Specifications
13.3.3 Biotest Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyper Immune Globulin Product Portfolios and Specifications
13.4.3 Kedrion Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyper Immune Globulin Product Portfolios and Specifications
13.5.3 CBPO Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyper Immune Globulin Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyper Immune Globulin Product Portfolios and Specifications
13.7.3 Kamada Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyper Immune Globulin Product Portfolios and Specifications
13.8.3 CNBG Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyper Immune Globulin Product Portfolios and Specifications
13.9.3 Hualan Bio Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyper Immune Globulin Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyper Immune Globulin Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyper Immune Globulin Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hyper Immune Globulin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hyper Immune Globulin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hyper Immune Globulin by Country/Region, 2018, 2022 & 2029
2.2 Hyper Immune Globulin Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Others
2.3 Hyper Immune Globulin Sales by Type
2.3.1 Global Hyper Immune Globulin Sales Market Share by Type (2018-2023)
2.3.2 Global Hyper Immune Globulin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hyper Immune Globulin Sale Price by Type (2018-2023)
2.4 Hyper Immune Globulin Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Others
2.5 Hyper Immune Globulin Sales by Application
2.5.1 Global Hyper Immune Globulin Sale Market Share by Application (2018-2023)
2.5.2 Global Hyper Immune Globulin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hyper Immune Globulin Sale Price by Application (2018-2023)
3 GLOBAL HYPER IMMUNE GLOBULIN BY COMPANY
3.1 Global Hyper Immune Globulin Breakdown Data by Company
3.1.1 Global Hyper Immune Globulin Annual Sales by Company (2018-2023)
3.1.2 Global Hyper Immune Globulin Sales Market Share by Company (2018-2023)
3.2 Global Hyper Immune Globulin Annual Revenue by Company (2018-2023)
3.2.1 Global Hyper Immune Globulin Revenue by Company (2018-2023)
3.2.2 Global Hyper Immune Globulin Revenue Market Share by Company (2018-2023)
3.3 Global Hyper Immune Globulin Sale Price by Company
3.4 Key Manufacturers Hyper Immune Globulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyper Immune Globulin Product Location Distribution
3.4.2 Players Hyper Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HYPER IMMUNE GLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Hyper Immune Globulin Market Size by Geographic Region (2018-2023)
4.1.1 Global Hyper Immune Globulin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hyper Immune Globulin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyper Immune Globulin Market Size by Country/Region (2018-2023)
4.2.1 Global Hyper Immune Globulin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hyper Immune Globulin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyper Immune Globulin Sales Growth
4.4 APAC Hyper Immune Globulin Sales Growth
4.5 Europe Hyper Immune Globulin Sales Growth
4.6 Middle East & Africa Hyper Immune Globulin Sales Growth
5 AMERICAS
5.1 Americas Hyper Immune Globulin Sales by Country
5.1.1 Americas Hyper Immune Globulin Sales by Country (2018-2023)
5.1.2 Americas Hyper Immune Globulin Revenue by Country (2018-2023)
5.2 Americas Hyper Immune Globulin Sales by Type
5.3 Americas Hyper Immune Globulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyper Immune Globulin Sales by Region
6.1.1 APAC Hyper Immune Globulin Sales by Region (2018-2023)
6.1.2 APAC Hyper Immune Globulin Revenue by Region (2018-2023)
6.2 APAC Hyper Immune Globulin Sales by Type
6.3 APAC Hyper Immune Globulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hyper Immune Globulin by Country
7.1.1 Europe Hyper Immune Globulin Sales by Country (2018-2023)
7.1.2 Europe Hyper Immune Globulin Revenue by Country (2018-2023)
7.2 Europe Hyper Immune Globulin Sales by Type
7.3 Europe Hyper Immune Globulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hyper Immune Globulin by Country
8.1.1 Middle East & Africa Hyper Immune Globulin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hyper Immune Globulin Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyper Immune Globulin Sales by Type
8.3 Middle East & Africa Hyper Immune Globulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyper Immune Globulin
10.3 Manufacturing Process Analysis of Hyper Immune Globulin
10.4 Industry Chain Structure of Hyper Immune Globulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyper Immune Globulin Distributors
11.3 Hyper Immune Globulin Customer
12 WORLD FORECAST REVIEW FOR HYPER IMMUNE GLOBULIN BY GEOGRAPHIC REGION
12.1 Global Hyper Immune Globulin Market Size Forecast by Region
12.1.1 Global Hyper Immune Globulin Forecast by Region (2024-2029)
12.1.2 Global Hyper Immune Globulin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyper Immune Globulin Forecast by Type
12.7 Global Hyper Immune Globulin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyper Immune Globulin Product Portfolios and Specifications
13.1.3 CSL Behring Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyper Immune Globulin Product Portfolios and Specifications
13.2.3 Grifols Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyper Immune Globulin Product Portfolios and Specifications
13.3.3 Biotest Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyper Immune Globulin Product Portfolios and Specifications
13.4.3 Kedrion Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyper Immune Globulin Product Portfolios and Specifications
13.5.3 CBPO Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyper Immune Globulin Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyper Immune Globulin Product Portfolios and Specifications
13.7.3 Kamada Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyper Immune Globulin Product Portfolios and Specifications
13.8.3 CNBG Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyper Immune Globulin Product Portfolios and Specifications
13.9.3 Hualan Bio Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyper Immune Globulin Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyper Immune Globulin Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyper Immune Globulin Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hyper Immune Globulin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyper Immune Globulin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Others
Table 8. Global Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 9. Global Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Table 10. Global Hyper Immune Globulin Revenue by Type (2018-2023) & ($ million)
Table 11. Global Hyper Immune Globulin Revenue Market Share by Type (2018-2023)
Table 12. Global Hyper Immune Globulin Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 14. Global Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Table 15. Global Hyper Immune Globulin Revenue by Application (2018-2023)
Table 16. Global Hyper Immune Globulin Revenue Market Share by Application (2018-2023)
Table 17. Global Hyper Immune Globulin Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Hyper Immune Globulin Sales by Company (2018-2023) & (K Units)
Table 19. Global Hyper Immune Globulin Sales Market Share by Company (2018-2023)
Table 20. Global Hyper Immune Globulin Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Hyper Immune Globulin Revenue Market Share by Company (2018-2023)
Table 22. Global Hyper Immune Globulin Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Hyper Immune Globulin Producing Area Distribution and Sales Area
Table 24. Players Hyper Immune Globulin Products Offered
Table 25. Hyper Immune Globulin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Hyper Immune Globulin Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Hyper Immune Globulin Sales Market Share Geographic Region (2018-2023)
Table 30. Global Hyper Immune Globulin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Hyper Immune Globulin Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Hyper Immune Globulin Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Hyper Immune Globulin Sales Market Share by Country/Region (2018-2023)
Table 34. Global Hyper Immune Globulin Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Hyper Immune Globulin Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 37. Americas Hyper Immune Globulin Sales Market Share by Country (2018-2023)
Table 38. Americas Hyper Immune Globulin Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Hyper Immune Globulin Revenue Market Share by Country (2018-2023)
Table 40. Americas Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 41. Americas Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 42. APAC Hyper Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 43. APAC Hyper Immune Globulin Sales Market Share by Region (2018-2023)
Table 44. APAC Hyper Immune Globulin Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Hyper Immune Globulin Revenue Market Share by Region (2018-2023)
Table 46. APAC Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 47. APAC Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 48. Europe Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 49. Europe Hyper Immune Globulin Sales Market Share by Country (2018-2023)
Table 50. Europe Hyper Immune Globulin Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Hyper Immune Globulin Revenue Market Share by Country (2018-2023)
Table 52. Europe Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 53. Europe Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Hyper Immune Globulin Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hyper Immune Globulin Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Hyper Immune Globulin
Table 61. Key Market Challenges & Risks of Hyper Immune Globulin
Table 62. Key Industry Trends of Hyper Immune Globulin
Table 63. Hyper Immune Globulin Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hyper Immune Globulin Distributors List
Table 66. Hyper Immune Globulin Customer List
Table 67. Global Hyper Immune Globulin Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Hyper Immune Globulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Hyper Immune Globulin Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Hyper Immune Globulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Hyper Immune Globulin Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Hyper Immune Globulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Hyper Immune Globulin Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Hyper Immune Globulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Hyper Immune Globulin Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Hyper Immune Globulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Hyper Immune Globulin Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Hyper Immune Globulin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Hyper Immune Globulin Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Hyper Immune Globulin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Hyper Immune Globulin Product Portfolios and Specifications
Table 83. CSL Behring Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Grifols Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 87. Grifols Hyper Immune Globulin Product Portfolios and Specifications
Table 88. Grifols Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Grifols Main Business
Table 90. Grifols Latest Developments
Table 91. Biotest Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 92. Biotest Hyper Immune Globulin Product Portfolios and Specifications
Table 93. Biotest Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Biotest Main Business
Table 95. Biotest Latest Developments
Table 96. Kedrion Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 97. Kedrion Hyper Immune Globulin Product Portfolios and Specifications
Table 98. Kedrion Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Kedrion Main Business
Table 100. Kedrion Latest Developments
Table 101. CBPO Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 102. CBPO Hyper Immune Globulin Product Portfolios and Specifications
Table 103. CBPO Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. CBPO Main Business
Table 105. CBPO Latest Developments
Table 106. Emergent (Cangene) Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 107. Emergent (Cangene) Hyper Immune Globulin Product Portfolios and Specifications
Table 108. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Emergent (Cangene) Main Business
Table 110. Emergent (Cangene) Latest Developments
Table 111. Kamada Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Hyper Immune Globulin Product Portfolios and Specifications
Table 113. Kamada Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. CNBG Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 117. CNBG Hyper Immune Globulin Product Portfolios and Specifications
Table 118. CNBG Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. CNBG Main Business
Table 120. CNBG Latest Developments
Table 121. Hualan Bio Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Bio Hyper Immune Globulin Product Portfolios and Specifications
Table 123. Hualan Bio Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Hualan Bio Main Business
Table 125. Hualan Bio Latest Developments
Table 126. Shanghai RAAS Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Hyper Immune Globulin Product Portfolios and Specifications
Table 128. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Main Business
Table 130. Shanghai RAAS Latest Developments
Table 131. Sichuan Yuanda Shuyang Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Yuanda Shuyang Hyper Immune Globulin Product Portfolios and Specifications
Table 133. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Sichuan Yuanda Shuyang Main Business
Table 135. Sichuan Yuanda Shuyang Latest Developments
Table 136. ADMA Biologics Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 137. ADMA Biologics Hyper Immune Globulin Product Portfolios and Specifications
Table 138. ADMA Biologics Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. ADMA Biologics Main Business
Table 140. ADMA Biologics Latest Developments
Table 1. Hyper Immune Globulin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyper Immune Globulin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Others
Table 8. Global Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 9. Global Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Table 10. Global Hyper Immune Globulin Revenue by Type (2018-2023) & ($ million)
Table 11. Global Hyper Immune Globulin Revenue Market Share by Type (2018-2023)
Table 12. Global Hyper Immune Globulin Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 14. Global Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Table 15. Global Hyper Immune Globulin Revenue by Application (2018-2023)
Table 16. Global Hyper Immune Globulin Revenue Market Share by Application (2018-2023)
Table 17. Global Hyper Immune Globulin Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Hyper Immune Globulin Sales by Company (2018-2023) & (K Units)
Table 19. Global Hyper Immune Globulin Sales Market Share by Company (2018-2023)
Table 20. Global Hyper Immune Globulin Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Hyper Immune Globulin Revenue Market Share by Company (2018-2023)
Table 22. Global Hyper Immune Globulin Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Hyper Immune Globulin Producing Area Distribution and Sales Area
Table 24. Players Hyper Immune Globulin Products Offered
Table 25. Hyper Immune Globulin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Hyper Immune Globulin Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Hyper Immune Globulin Sales Market Share Geographic Region (2018-2023)
Table 30. Global Hyper Immune Globulin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Hyper Immune Globulin Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Hyper Immune Globulin Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Hyper Immune Globulin Sales Market Share by Country/Region (2018-2023)
Table 34. Global Hyper Immune Globulin Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Hyper Immune Globulin Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 37. Americas Hyper Immune Globulin Sales Market Share by Country (2018-2023)
Table 38. Americas Hyper Immune Globulin Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Hyper Immune Globulin Revenue Market Share by Country (2018-2023)
Table 40. Americas Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 41. Americas Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 42. APAC Hyper Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 43. APAC Hyper Immune Globulin Sales Market Share by Region (2018-2023)
Table 44. APAC Hyper Immune Globulin Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Hyper Immune Globulin Revenue Market Share by Region (2018-2023)
Table 46. APAC Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 47. APAC Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 48. Europe Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 49. Europe Hyper Immune Globulin Sales Market Share by Country (2018-2023)
Table 50. Europe Hyper Immune Globulin Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Hyper Immune Globulin Revenue Market Share by Country (2018-2023)
Table 52. Europe Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 53. Europe Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Hyper Immune Globulin Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hyper Immune Globulin Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Hyper Immune Globulin Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Hyper Immune Globulin Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Hyper Immune Globulin
Table 61. Key Market Challenges & Risks of Hyper Immune Globulin
Table 62. Key Industry Trends of Hyper Immune Globulin
Table 63. Hyper Immune Globulin Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hyper Immune Globulin Distributors List
Table 66. Hyper Immune Globulin Customer List
Table 67. Global Hyper Immune Globulin Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Hyper Immune Globulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Hyper Immune Globulin Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Hyper Immune Globulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Hyper Immune Globulin Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Hyper Immune Globulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Hyper Immune Globulin Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Hyper Immune Globulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Hyper Immune Globulin Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Hyper Immune Globulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Hyper Immune Globulin Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Hyper Immune Globulin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Hyper Immune Globulin Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Hyper Immune Globulin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Hyper Immune Globulin Product Portfolios and Specifications
Table 83. CSL Behring Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Grifols Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 87. Grifols Hyper Immune Globulin Product Portfolios and Specifications
Table 88. Grifols Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Grifols Main Business
Table 90. Grifols Latest Developments
Table 91. Biotest Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 92. Biotest Hyper Immune Globulin Product Portfolios and Specifications
Table 93. Biotest Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Biotest Main Business
Table 95. Biotest Latest Developments
Table 96. Kedrion Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 97. Kedrion Hyper Immune Globulin Product Portfolios and Specifications
Table 98. Kedrion Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Kedrion Main Business
Table 100. Kedrion Latest Developments
Table 101. CBPO Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 102. CBPO Hyper Immune Globulin Product Portfolios and Specifications
Table 103. CBPO Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. CBPO Main Business
Table 105. CBPO Latest Developments
Table 106. Emergent (Cangene) Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 107. Emergent (Cangene) Hyper Immune Globulin Product Portfolios and Specifications
Table 108. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Emergent (Cangene) Main Business
Table 110. Emergent (Cangene) Latest Developments
Table 111. Kamada Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Hyper Immune Globulin Product Portfolios and Specifications
Table 113. Kamada Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. CNBG Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 117. CNBG Hyper Immune Globulin Product Portfolios and Specifications
Table 118. CNBG Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. CNBG Main Business
Table 120. CNBG Latest Developments
Table 121. Hualan Bio Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Bio Hyper Immune Globulin Product Portfolios and Specifications
Table 123. Hualan Bio Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Hualan Bio Main Business
Table 125. Hualan Bio Latest Developments
Table 126. Shanghai RAAS Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Hyper Immune Globulin Product Portfolios and Specifications
Table 128. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Main Business
Table 130. Shanghai RAAS Latest Developments
Table 131. Sichuan Yuanda Shuyang Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Yuanda Shuyang Hyper Immune Globulin Product Portfolios and Specifications
Table 133. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Sichuan Yuanda Shuyang Main Business
Table 135. Sichuan Yuanda Shuyang Latest Developments
Table 136. ADMA Biologics Basic Information, Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 137. ADMA Biologics Hyper Immune Globulin Product Portfolios and Specifications
Table 138. ADMA Biologics Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. ADMA Biologics Main Business
Table 140. ADMA Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hyper Immune Globulin
Figure 2. Hyper Immune Globulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyper Immune Globulin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hyper Immune Globulin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyper Immune Globulin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hepatitis B Immunoglobulins
Figure 10. Product Picture of Rabies Immunoglobulins
Figure 11. Product Picture of Tetanus Immunoglobulins
Figure 12. Product Picture of Rho(D) Immunoglobulins
Figure 13. Product Picture of Others
Figure 14. Global Hyper Immune Globulin Sales Market Share by Type in 2022
Figure 15. Global Hyper Immune Globulin Revenue Market Share by Type (2018-2023)
Figure 16. Hyper Immune Globulin Consumed in Government Institutions
Figure 17. Global Hyper Immune Globulin Market: Government Institutions (2018-2023) & (K Units)
Figure 18. Hyper Immune Globulin Consumed in Private Sector
Figure 19. Global Hyper Immune Globulin Market: Private Sector (2018-2023) & (K Units)
Figure 20. Hyper Immune Globulin Consumed in Others
Figure 21. Global Hyper Immune Globulin Market: Others (2018-2023) & (K Units)
Figure 22. Global Hyper Immune Globulin Sales Market Share by Application (2022)
Figure 23. Global Hyper Immune Globulin Revenue Market Share by Application in 2022
Figure 24. Hyper Immune Globulin Sales Market by Company in 2022 (K Units)
Figure 25. Global Hyper Immune Globulin Sales Market Share by Company in 2022
Figure 26. Hyper Immune Globulin Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Hyper Immune Globulin Revenue Market Share by Company in 2022
Figure 28. Global Hyper Immune Globulin Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Hyper Immune Globulin Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 31. Americas Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 32. APAC Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 33. APAC Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 34. Europe Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 35. Europe Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 38. Americas Hyper Immune Globulin Sales Market Share by Country in 2022
Figure 39. Americas Hyper Immune Globulin Revenue Market Share by Country in 2022
Figure 40. Americas Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 41. Americas Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 42. United States Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Hyper Immune Globulin Sales Market Share by Region in 2022
Figure 47. APAC Hyper Immune Globulin Revenue Market Share by Regions in 2022
Figure 48. APAC Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 49. APAC Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 50. China Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Hyper Immune Globulin Sales Market Share by Country in 2022
Figure 58. Europe Hyper Immune Globulin Revenue Market Share by Country in 2022
Figure 59. Europe Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 60. Europe Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 61. Germany Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Hyper Immune Globulin Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 70. Egypt Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Hyper Immune Globulin in 2022
Figure 76. Manufacturing Process Analysis of Hyper Immune Globulin
Figure 77. Industry Chain Structure of Hyper Immune Globulin
Figure 78. Channels of Distribution
Figure 79. Global Hyper Immune Globulin Sales Market Forecast by Region (2024-2029)
Figure 80. Global Hyper Immune Globulin Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Hyper Immune Globulin Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Hyper Immune Globulin Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Hyper Immune Globulin Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Hyper Immune Globulin Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Hyper Immune Globulin
Figure 2. Hyper Immune Globulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyper Immune Globulin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hyper Immune Globulin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyper Immune Globulin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hepatitis B Immunoglobulins
Figure 10. Product Picture of Rabies Immunoglobulins
Figure 11. Product Picture of Tetanus Immunoglobulins
Figure 12. Product Picture of Rho(D) Immunoglobulins
Figure 13. Product Picture of Others
Figure 14. Global Hyper Immune Globulin Sales Market Share by Type in 2022
Figure 15. Global Hyper Immune Globulin Revenue Market Share by Type (2018-2023)
Figure 16. Hyper Immune Globulin Consumed in Government Institutions
Figure 17. Global Hyper Immune Globulin Market: Government Institutions (2018-2023) & (K Units)
Figure 18. Hyper Immune Globulin Consumed in Private Sector
Figure 19. Global Hyper Immune Globulin Market: Private Sector (2018-2023) & (K Units)
Figure 20. Hyper Immune Globulin Consumed in Others
Figure 21. Global Hyper Immune Globulin Market: Others (2018-2023) & (K Units)
Figure 22. Global Hyper Immune Globulin Sales Market Share by Application (2022)
Figure 23. Global Hyper Immune Globulin Revenue Market Share by Application in 2022
Figure 24. Hyper Immune Globulin Sales Market by Company in 2022 (K Units)
Figure 25. Global Hyper Immune Globulin Sales Market Share by Company in 2022
Figure 26. Hyper Immune Globulin Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Hyper Immune Globulin Revenue Market Share by Company in 2022
Figure 28. Global Hyper Immune Globulin Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Hyper Immune Globulin Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 31. Americas Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 32. APAC Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 33. APAC Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 34. Europe Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 35. Europe Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Hyper Immune Globulin Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Hyper Immune Globulin Revenue 2018-2023 ($ Millions)
Figure 38. Americas Hyper Immune Globulin Sales Market Share by Country in 2022
Figure 39. Americas Hyper Immune Globulin Revenue Market Share by Country in 2022
Figure 40. Americas Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 41. Americas Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 42. United States Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Hyper Immune Globulin Sales Market Share by Region in 2022
Figure 47. APAC Hyper Immune Globulin Revenue Market Share by Regions in 2022
Figure 48. APAC Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 49. APAC Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 50. China Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Hyper Immune Globulin Sales Market Share by Country in 2022
Figure 58. Europe Hyper Immune Globulin Revenue Market Share by Country in 2022
Figure 59. Europe Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 60. Europe Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 61. Germany Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Hyper Immune Globulin Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Figure 70. Egypt Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Hyper Immune Globulin Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Hyper Immune Globulin in 2022
Figure 76. Manufacturing Process Analysis of Hyper Immune Globulin
Figure 77. Industry Chain Structure of Hyper Immune Globulin
Figure 78. Channels of Distribution
Figure 79. Global Hyper Immune Globulin Sales Market Forecast by Region (2024-2029)
Figure 80. Global Hyper Immune Globulin Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Hyper Immune Globulin Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Hyper Immune Globulin Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Hyper Immune Globulin Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Hyper Immune Globulin Revenue Market Share Forecast by Application (2024-2029)
